Acebilustat

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAcebilustat
Drug Alias NameAcebilustatum阿西鲁司特阿比司他EP-501CTX-4430
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukotriene A-4 hydrolase inhibitors
TargetsLeukotriene A-4 hydrolase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Acne VulgarisCystic Fibrosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCeltaxsys Inc
China Registration ClassN/A

Develop Information

Active CompaniesStanford University
Inactive CompaniesCeltaxsys Inc
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsAcne VulgarisCystic FibrosisPneumonia

Other Information

ATC CodeN/A
Related LinksN/A